Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DMAA · as of Jun 9, 2026
Key Statistics
Explore Drugs Made In America Acquisition Corp. Ordinary Shares Data
dmaa stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
dmaa competitorsDMAA
ALF
LOKV
MLAC
OYSE
RTACStock Performance
Full HistoryAbout Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. Ordinary Shares Drugs Made In America Acquisition Corp. functions as a special purpose acquisition company, commonly known as a blank check company. Its core mission is to seek out and ultimately acquire one or more …
what is drugs made in america acquisition corp. ordinary shares · dmaa stock overview · drugs made in america acquisition corp. ordinary shares company profile · who is drugs made in america acquisition corp. ordinary shares ceo · dmaa NASDAQ · drugs made in america acquisition corp. ordinary shares headquarters · drugs made in america acquisition corp. ordinary shares business segments
About Stock Overview & Key Data
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Jan 27, 2025. As of the latest trading session, DMAA stock price is $10.62, with a market capitalization of $358.1M. The stock has returned +4.43% over the past 12 months and +2.31% year-to-date.
In fiscal year 2025, Drugs Made In America Acquisition Corp. Ordinary Shares reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) stock price is $10.62. The stock is traded on NASDAQ under the ticker symbol DMAA. The 52-week range is $10.16 – $10.62.